Viewing nowCANTACAN 8 mg (Candesartan Cilexetil)
Candesartan Cilexetil 8mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201506685 · Approved 2015.09.22 · Insurance code 693901850
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
This medication is used to reliably control blood pressure in patients with essential hypertension. It is also administered additionally in heart failure patients with impaired left ventricular systolic function when ACE inhibitors are insufficient or poorly tolerated, thereby improving heart failure symptoms. It supports cardiac function and helps enhance the quality of life for patients.
This medicine should be taken at the same time each day, regardless of meals. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion (Intravascular volume depletion): For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Essential hypertension Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. Heart failure Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so treatment must be discontinued immediately if pregnancy is confirmed. This medication should not be administered to women who are allergic to this drug or its components, are pregnant or breastfeeding, have severe liver disease or biliary obstruction, have a history of angioedema, certain hereditary angioedema conditions, or primary hyperaldosteronism. Patients with lactose intolerance or certain genetic metabolic disorders should not take this drug. Careful administration is required in elderly patients, those with hyperkalemia, mild to moderate liver impairment, certain valvular heart diseases or obstructive cardiomyopathy, ischemic heart disease, cerebrovascular disorders, renal artery stenosis, those with reduced intravascular effective blood volume, diminished renal function, patients who have recently received a kidney transplant, and those under 18 years of age. Common side effects include dizziness, back pain, and respiratory infections, and serious side effects, though rare, may include leukopenia, hepatic abnormalities, angioedema, myalgia, and worsening renal function, necessitating immediate consultation with a physician if symptoms occur. In heart failure patients, hypotension, hyperkalemia, and renal function impairment may occur, so regular monitoring of serum potassium and creatinine levels is important. This medication has a blood pressure-lowering effect; therefore, caution is required as dizziness or fainting may occur if blood pressure drops too low, especially in patients undergoing hemodialysis or on strict salt restrictions or diuretics, necessitating careful dose adjustments and close observation. This medication may enhance the effects of other antihypertensive agents, so patients should notify their physician if they are taking other medications and take care when using them together. When combined with potassium-sparing diuretics or potassium supplements, serum potassium levels may rise to dangerous levels, requiring regular blood tests for monitoring. Pregnant women or women planning to become pregnant should not use this medication, and breastfeeding mothers are advised to avoid it as well. Safety and effectiveness in children and adolescents have not been established, so use is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, requiring immediate medical attention. This medication should be stored out of reach of children, and transfer to other containers may affect its quality, so it is advisable to keep it in its original packaging. Caution should be exercised when driving or operating machinery, as dizziness or lethargy may occur due to medication intake.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the efficacy and safety of the drug.
Pink, double-convex, round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCandesartan Cilexetil 8mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Yuhans Chemical Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Yuhan Corporation

Candesartan Cilexetil 32mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Jong Kun Dang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.